1,646 top medical experts on Renal Cell Carcinoma across 58 countries and 41 U.S. states, including 1,552 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Renal Cell Carcinoma: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the kidneys. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adenocarcinoma (5,212), Kidney Neoplasms (5,066).
  4. Clinical Trials ClinicalTrials.gov : at least 1,525 including 126 Active, 703 Completed, 267 Recruiting
  5. Synonyms: Renal Cell Adenocarcinoma,  Hypernephroid Carcinoma,  Grawitz Tumor,  Hypernephroma,  Renal Carcinoma


  

        

                    


    Computing Expert Listing ...

);